Related Experiment Video
Updated: Jun 30, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
New insights into stroke in chronic kidney disease
1Department of Neurology, University of Pennsylvania School of Medicine; Philadelphia, PA, USA. Sami.Khella@uphs.upenn.edu
Insights
Patients with chronic kidney disease (CKD) face increased stroke risk. Management focuses on hypertension control, antiplatelet therapy for secondary prevention, and anticoagulation for atrial fibrillation, with limited roles for statins and conflicting data on carotid stenting.
Area of Science:
- Nephrology
- Neurology
- Cardiovascular Medicine
Background:
- Patients with chronic kidney disease (CKD) exhibit a higher predisposition to stroke.
- Stroke risk escalates with declining estimated glomerular filtration rate in CKD patients.
Purpose of the Study:
- To review the pathological mechanisms of stroke in the CKD population.
- To examine primary and secondary stroke prevention strategies for CKD patients.
Main Methods:
- Literature review of pathologic mechanisms and treatment options for stroke in CKD.
- Analysis of evidence for antiplatelet agents, anticoagulants, surgery, and carotid stenting.
Main Results:
- Hypertension control is crucial for reducing stroke risk in CKD.
- Antiplatelet agents are beneficial for secondary stroke prevention in atherosclerotic CKD patients.
- Warfarin may benefit CKD patients with atrial fibrillation; statins show limited utility in specific CKD subgroups.
Conclusions:
- Stroke prevention in CKD requires tailored strategies, including hypertension management and appropriate antithrombotic therapy.
- Carotid endarterectomy is viable in select cases, while carotid stenting data remain inconclusive.
Abstract:
Patients with chronic kidney disease (CKD) are predisposed to stroke, especially as the estimated glomerular filtration rate decreases. This update reviews the pathologic mechanisms particular to this stroke population. The treatment for primary and secondary prevention of stroke is reviewed with respect to antiplatelet agents, anticoagulants, surgery, and carotid stenting. The control of chronic hypertension is particularly important in reducing stroke risk in CKD. In patients with prior stroke from atherosclerosis, antiplatelet agents are most beneficial in reducing secondary stroke risk. Those with atrial fibrillation and CKD may benefit from warfarin anticoagulation. Statins in CKD for stroke reduction in diabetics receiving dialysis are not useful, and the data are pending for their use in stroke reduction in the general CKD population. In carefully selected cases, carotid endarterectomy can be a treatment. The data on carotid stenting are conflicting.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction
